Antibody Drugs Market Analysis 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antibody Drugs Market
Antibody Drugs Market Analysis: By Disease Cure (Central Nervous System Ailment, Allergic Diseases, Cancer, Infections and Others); and By Geography - Forecast(2018 - 2023)
Report Code : HCR 0153
Updated Date: 18 February, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Antibody Drugs – Market Overview
2. Executive Summary
3. Antibody Drugs Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Antibody Drugs – Market Forces
   4.1. Drivers
      4.1.1. Developing medical infrastructure in developing regions
      4.1.2. Increasing medical tourism in emerging nations
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Antibody Drugs – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Antibody Drugs Market, By Disease Cure
   6.1. Central nervous system ailment
   6.2. Allergic diseases
   6.3. Cancer
   6.4. Infections
   6.5. Others
7. Global Antibody Drugs Market, By Geography
   7.1. Europe
      7.1.1. Germany
      7.1.2. France
      7.1.3. Italy
      7.1.4. Spain
      7.1.5. Russia
      7.1.6. U.K.
      7.1.7. Rest of Europe
   7.2. Asia Pacific
      7.2.1. China
      7.2.2. India
      7.2.3. Japan
      7.2.4. South Korea
      7.2.5. Rest of Asia-Pacific
   7.3. North America
      7.3.1. U.S.
      7.3.2. Canada
      7.3.3. Mexico
   7.4. Rest of the World (RoW)
      7.4.1. Brazil
      7.4.2. Rest of RoW
8. Antibody Drugs – Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply- Contract
9. Company Profiles
   9.1. Abbott Laboratories
      9.1.1.  Introduction
      9.1.2. Financials
      9.1.3. Key Insights
      9.1.4. Key Strategy
      9.1.5. Product Portfolio
      9.1.6. SWOT Analysis
   9.2. Bayer HealthCare AG
      9.2.1. Introduction
      9.2.2. Financials
      9.2.3. Key Insights
      9.2.4. Key Strategy
      9.2.5. Product Portfolio
      9.2.6. SWOT Analysis
   9.3. Eli Lilly and Co.     
      9.3.1.  Introduction
      9.3.2. Financials
      9.3.3. Key Insights
      9.3.4. Key Strategy
      9.3.5. Product Portfolio
      9.3.6. SWOT Analysis
   9.4. UCB Company     
      9.4.1. Introduction
      9.4.2. Financials
      9.4.3. Key Insights
      9.4.4. Key Strategy
      9.4.5. Product Portfolio
      9.4.6. SWOT Analysis
   9.5. Merck & Co.  
      9.5.1. Introduction
      9.5.2. Financials
      9.5.3. Key Insights
      9.5.4. Key Strategy
      9.5.5. Product Portfolio
      9.5.6. SWOT Analysis
   9.6. Johnson & Johnson    
      9.6.1. Introduction
      9.6.2. Financials
      9.6.3. Key Insights
      9.6.4. Key Strategy
      9.6.5. Product Portfolio
      9.6.6. SWOT Analysis
   9.7. Glaxo Smith Kline Plc. 
      9.7.1. Introduction
      9.7.2. Financials
      9.7.3. Key Insights
      9.7.4. Key Strategy
      9.7.5. Product Portfolio
      9.7.6. SWOT Analysis
   9.8. Bristol-Myers Squibb   
      9.8.1. Introduction
      9.8.2. Financials
      9.8.3. Key Insights
      9.8.4. Key Strategy
      9.8.5. Product Portfolio
      9.8.6. SWOT Analysis
   9.9. Alexion Pharmaceuticals
      9.9.1. Introduction
      9.9.2. Financials
      9.9.3. Key Insights
      9.9.4. Key Strategy
      9.9.5. Product Portfolio
      9.9.6. SWOT Analysis
   9.10. Seattle Genetics Inc.     
      9.10.1. Introduction
      9.10.2. Financials
      9.10.3. Key Insights
      9.10.4. Key Strategy
      9.10.5. Product Portfolio
      9.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix

   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Antibody drugs are the medicines that make use of the body’s own immune system to identify, locate and eliminate cells which are responsible for the target disease. These types of have been successful in attracting the attention of researchers worldwide owing to their characteristic features such as fewer side effects and high efficacy in curing certain diseases which were previously untreatable. These drugs show promising efficacy for the treatment of certain diseases for which no equally effective treatment is available. Antibody drugs are primarily used for the treatment of diseases such as central nervous system ailments, allergic diseases, cancer, and infection. This report is focused on identifying market size for anti-body drugs. Increasing medical infrastructure in emerging economies and developing medical tourism in these countries along with increasing R&D activities in the field of anti-body drugs is expected to drive the demand for anti-body drugs globally.

This report identifies the anti-body drugs market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to anti-body drugs market.

Antibody Drugs Market

Globally North America is the largest market for anti-body drugs in 2015 followed by Europe and Asia-Pacific as second and third largest regional markets respectively. However anti-body market in Asia-Pacific region is expected to grow fastest due to increasing demand of anti-body drugs in the region due to developing medical infrastructure in the region which is also resulting into growing medical infrastructure in the region.
  • On the basis of diseases cured by anti-body drug type this report classified as follows covering all major types of diseases cured by these drugs: Central nervous system ailment, Allergic diseases, Cancer, Infections and Others
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for anti-body drugs in each of the region.

This report identifies all the major companies operating in the global anti-body drugs market. Some of the major companies’ profiles in detail are as follows:
  • Abbott Laboratories
  • Bayer HealthCare AG
  • Eli Lilly and Co.     
  • UCB Company     
  • Merck & Co.  
  • Johnson & Johnson
List of Tables

Table1: Antibody Drugs Market Overview 2017-2023
Table2: Antibody Drugs Market Leader Analysis 2017-2018 (US$)
Table3: Antibody Drugs Market Product Analysis 2017-2018 (US$)
Table4: Antibody Drugs Market End User Analysis 2017-2018 (US$)
Table5: Antibody Drugs Market Patent Analysis 2013-2018* (US$)
Table6: Antibody Drugs Market Financial Analysis 2017-2018 (US$)
Table7: Antibody Drugs Market Driver Analysis 2017-2018 (US$)
Table8: Antibody Drugs Market Challenges Analysis 2017-2018 (US$)
Table9: Antibody Drugs Market Constraint Analysis 2017-2018 (US$)
Table10: Antibody Drugs Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table11: Antibody Drugs Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table12: Antibody Drugs Market Threat of Substitutes Analysis 2017-2018 (US$)
Table13: Antibody Drugs Market Threat of New Entrants Analysis 2017-2018 (US$)
Table14: Antibody Drugs Market Degree of Competition Analysis 2017-2018 (US$)
Table15: Antibody Drugs Market Value Chain Analysis 2017-2018 (US$)
Table16: Antibody Drugs Market Pricing Analysis 2018-2023 (US$)
Table17: Antibody Drugs Market Opportunities Analysis 2018-2023 (US$)
Table18: Antibody Drugs Market Product Life Cycle Analysis 2018-2023 (US$)
Table19: Antibody Drugs Market Supplier Analysis 2017-2018 (US$)
Table20: Antibody Drugs Market Distributor Analysis 2017-2018 (US$)
Table21: Antibody Drugs Market Trend Analysis 2017-2018 (US$)
Table22: Antibody Drugs Market Size 2017 (US$)
Table23: Antibody Drugs Market Forecast Analysis 2018-2023 (US$)
Table24: Antibody Drugs Market Sales Forecast Analysis 2018-2023 (Units)
Table25: Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table26: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Central nervous system ailment, 2018-2023 ($)
Table27: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Allergic diseases, 2018-2023 ($)
Table28: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Cancer, 2018-2023 ($)
Table29: Antibody Drugs Market By Disease Cure, Revenue & Volume,By Infections, 2018-2023 ($)
Table30: North America Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table31: South america Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table32: Europe Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table33: APAC Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table34: Middle East & Africa Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table35: Russia Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table36: Israel Antibody Drugs Market, Revenue & Volume,By Disease Cure, 2018-2023 ($)
Table37: Top Companies 2017 (US$)Antibody Drugs Market, Revenue & Volume
Table38: Product Launch 2017-2018Antibody Drugs Market, Revenue & Volume
Table39: Mergers & Acquistions 2017-2018Antibody Drugs Market, Revenue & Volume


List of Figures

Figure 1: Overview of Antibody Drugs Market 2017-2023
Figure 2: Market Share Analysis for Antibody Drugs Market 2017 (US$)
Figure 3: Product Comparison in Antibody Drugs Market 2017-2018 (US$)
Figure 4: End User Profile for Antibody Drugs Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Antibody Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antibody Drugs Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Antibody Drugs Market 2017-2018
Figure 8: Ecosystem Analysis in Antibody Drugs Market 2017
Figure 9: Average Selling Price in Antibody Drugs Market 2017-2023
Figure 10: Top Opportunites in Antibody Drugs Market 2017-2018
Figure 11: Market Life Cycle Analysis in Antibody Drugs Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy Disease Cure Antibody Drugs Market Revenue, 2018-2023 ($)
Figure 13: Global Antibody Drugs Market - By Geography
Figure 14: Global Antibody Drugs Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 15: Global Antibody Drugs Market CAGR, By Geography, 2018-2023 (%)
Figure 16: North America Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 17: US Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 18: US GDP and Population, 2017-2018 ($)
Figure 19: US GDP – Composition of 2017, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2017-2018 ($)
Figure 21: Canada Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 22: Canada GDP and Population, 2017-2018 ($)
Figure 23: Canada GDP – Composition of 2017, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 25: Mexico Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 26: Mexico GDP and Population, 2017-2018 ($)
Figure 27: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 29: South America Antibody Drugs Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 30: Brazil Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil GDP and Population, 2017-2018 ($)
Figure 32: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 34: Venezuela Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 35: Venezuela GDP and Population, 2017-2018 ($)
Figure 36: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 38: Argentina Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 39: Argentina GDP and Population, 2017-2018 ($)
Figure 40: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 42: Ecuador Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 43: Ecuador GDP and Population, 2017-2018 ($)
Figure 44: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 46: Peru Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 47: Peru GDP and Population, 2017-2018 ($)
Figure 48: Peru GDP – Composition of 2017, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 50: Colombia Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 51: Colombia GDP and Population, 2017-2018 ($)
Figure 52: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 54: Costa Rica Antibody Drugs Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 55: Costa Rica GDP and Population, 2017-2018 ($)
Figure 56: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 58: Europe Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 59: U.K Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 60: U.K GDP and Population, 2017-2018 ($)
Figure 61: U.K GDP – Composition of 2017, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 63: Germany Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 64: Germany GDP and Population, 2017-2018 ($)
Figure 65: Germany GDP – Composition of 2017, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 67: Italy Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 68: Italy GDP and Population, 2017-2018 ($)
Figure 69: Italy GDP – Composition of 2017, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 71: France Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 72: France GDP and Population, 2017-2018 ($)
Figure 73: France GDP – Composition of 2017, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2017-2018 ($)
Figure 75: Netherlands Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 76: Netherlands GDP and Population, 2017-2018 ($)
Figure 77: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 79: Belgium Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 80: Belgium GDP and Population, 2017-2018 ($)
Figure 81: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 83: Spain Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 84: Spain GDP and Population, 2017-2018 ($)
Figure 85: Spain GDP – Composition of 2017, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 87: Denmark Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 88: Denmark GDP and Population, 2017-2018 ($)
Figure 89: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 91: APAC Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 92: China Antibody Drugs Market Value & Volume, 2018-2023
Figure 93: China GDP and Population, 2017-2018 ($)
Figure 94: China GDP – Composition of 2017, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2017-2018 ($)Antibody Drugs Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 96: Australia Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 97: Australia GDP and Population, 2017-2018 ($)
Figure 98: Australia GDP – Composition of 2017, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 100: South Korea Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 101: South Korea GDP and Population, 2017-2018 ($)
Figure 102: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 104: India Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 105: India GDP and Population, 2017-2018 ($)
Figure 106: India GDP – Composition of 2017, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2017-2018 ($)
Figure 108: Taiwan Antibody Drugs Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 109: Taiwan GDP and Population, 2017-2018 ($)
Figure 110: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 112: Malaysia Antibody Drugs Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 113: Malaysia GDP and Population, 2017-2018 ($)
Figure 114: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 116: Hong Kong Antibody Drugs Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 117: Hong Kong GDP and Population, 2017-2018 ($)
Figure 118: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 120: Middle East & Africa Antibody Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 121: Russia Antibody Drugs Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia GDP and Population, 2017-2018 ($)
Figure 123: Russia GDP – Composition of 2017, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 125: Israel Antibody Drugs Market Value & Volume, 2018-2023 ($)
Figure 126: Israel GDP and Population, 2017-2018 ($)
Figure 127: Israel GDP – Composition of 2017, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 129: Entropy Share, By Strategies, 2017-2018* (%)Antibody Drugs Market
Figure 130: Developments, 2017-2018*Antibody Drugs Market
Figure 131: Company 1 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 132: Company 1 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 133: Company 1 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 134: Company 2 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 135: Company 2 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 136: Company 2 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 137: Company 3Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 138: Company 3Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 139: Company 3Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 140: Company 4 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 141: Company 4 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 142: Company 4 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 143: Company 5 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 144: Company 5 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 145: Company 5 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 146: Company 6 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 147: Company 6 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 148: Company 6 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 149: Company 7 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 150: Company 7 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 151: Company 7 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 152: Company 8 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 153: Company 8 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 154: Company 8 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 155: Company 9 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 156: Company 9 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 157: Company 9 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 158: Company 10 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 159: Company 10 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 160: Company 10 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 161: Company 11 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 162: Company 11 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 163: Company 11 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 164: Company 12 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 165: Company 12 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 166: Company 12 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 167: Company 13Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 168: Company 13Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 169: Company 13Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 170: Company 14 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 171: Company 14 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 172: Company 14 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Figure 173: Company 15 Antibody Drugs Market Net Revenue, By Years, 2017-2018* ($)
Figure 174: Company 15 Antibody Drugs Market Net Revenue Share, By Business segments, 2017 (%)
Figure 175: Company 15 Antibody Drugs Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll